Blog Band - Page 264 of 299

01

Dec 2021

PharmaShots Interview: Cartesian Therapeutics’s Dr. Murat Kalayoglu Shares Insight on RNA Cell Therapy for an Autoimmune Disease

In an interview with PharmaShots, Dr. Murat Kalayoglu, MD, Ph.D., President, and Chief Executive Officer at Cartesian Therapeutics shared his insights on the P-I/IIa study of Descartes-08 for the treatment of the chronic autoimmune…

30

Nov 2021

VIEWPOINTS

PharmaShots Interview: Vivacare’s Mark Becker Shares Insight on the Digital Patient Education Service for Allergic Conditions

In an interview with PharmaShots, Mark Becker, MD, founder, President, and CEO at Vivacare shared his views on the new collaboration with Asthma and Allergy Network to provide a Digital patient…

29

Nov 2021

VIEWPOINTS

PharmaShots Interview: Guardant Health’s Kathryn Lang Shares Insight on the Data of Guardant360 Liquid Biopsy Test for the Treatment of Advanced Non-Small Cell Lung Cancer

In an interview with PharmaShots, Kathryn Lang, Vice President, Outcomes & Evidence at Guardant Health shared her views on the data from the VALUE study of Guardant360 liquid biopsy test for NSCLC Shots: The VALUE study evaluates the…

25

Nov 2021

TOP 20

Top 20 Prescription Drugs Based on 2020 Revenue

Innovative horizons are broadening continuously in the field of medicines. Health is not only limited to physical well-being, it also reflects the mental status Pharmaceutical medicines are advancing rapidly in every…

24

Nov 2021

VIEWPOINTS

PharmaShots Interview: Janssen’s Jan Wehkamp Shares Insight on the Data of Stelara (ustekinumab) for IBD and other Approved Indications and Presented 13 Abstracts at UEGW

In an interview with PharmaShots, Jan Wehkamp, M.D., Vice President, Gastroenterology Disease Area Leader for the Immunology Therapeutic Area at Janssen Research & Development shared his views on the data from 13 P-II…

23

Nov 2021

VIEWPOINTS

PharmaShots Interview: ProQR’s Daniel A. de Boer Shares Insight on Sepofarsen for the Treatment of Leber Congenital Amaurosis (LCA10)

In an interview with PharmaShots, Daniel A. de Boer, Founder, and CEO at ProQR shared his views on the P-II/III Illuminate study of sepofarsen for the treatment of leber congenital amaurosis (LCA10) Shots: The ongoing P-II/III Illuminate study…

22

Nov 2021

VIEWPOINTS

PharmaShots Interview: Takeda’s Chris Arendt Shares Insight on the Data of Alunbrig Presented at ESMO 2021

In an interview with PharmaShots, Chris Arendt, Head of the Oncology Therapeutic Area Unit at Takeda shared his views on the new data of Alunbrig in the P-III ALTA-1L study for the Treatment of ALK+ mNSCLC Shots: The…

18

Nov 2021

INSIGHTS+

Insights+: The US FDA New Drug Approvals in October 2021

The US FDA has approved 4 NDAs and 2 BLAs in 2021, leading to treatments for patients and advances in the health care industry The Center for Drug Evaluation and…

17

Nov 2021

VIEWPOINTS

PharmaShots Interview: NervGen’s Paul Brennan Shares Insights on NVG-291 and its Interim Data for the Treatment of Neurodegenerative Diseases

In an interview with PharmaShots, Paul Brennan, President, CEO & Director at NervGen shared his views on the interim data of NVG-291 for the treatment of Neurodegenerative Diseases Shots: The P-I clinical trials evaluate NVG-291…

16

Nov 2021

VIEWPOINTS

PharmaShots Interview: Paracrine’s Christopher J. Calhoun Shares Insight on the First Autologous, Device-Based Cell Therapy Platform

In an interview with PharmaShots, Christopher J. Calhoun, President & CEO at Paracrine shared his views on the transforming diabetes treatment with the first autologous, device-based cell therapy platform Shots: The company has developed…

PharmaShots Interview: Cartesian Therapeutics’s Dr. Murat Kalayoglu Shares Insight on RNA Cell Therapy for an Autoimmune Disease

PharmaShots Interview: Vivacare’s Mark Becker Shares Insight on the Digital Patient Education Service for Allergic Conditions

PharmaShots Interview: Guardant Health’s Kathryn Lang Shares Insight on the Data of Guardant360 Liquid Biopsy Test for the Treatment of Advanced Non-Small Cell Lung Cancer

Top 20 Prescription Drugs Based on 2020 Revenue

PharmaShots Interview: Janssen’s Jan Wehkamp Shares Insight on the Data of Stelara (ustekinumab) for IBD and other Approved Indications and Presented 13 Abstracts at UEGW

PharmaShots Interview: ProQR’s Daniel A. de Boer Shares Insight on Sepofarsen for the Treatment of Leber Congenital Amaurosis (LCA10)

PharmaShots Interview: Takeda’s Chris Arendt Shares Insight on the Data of Alunbrig Presented at ESMO 2021

Insights+: The US FDA New Drug Approvals in October 2021

PharmaShots Interview: NervGen’s Paul Brennan Shares Insights on NVG-291 and its Interim Data for the Treatment of Neurodegenerative Diseases

PharmaShots Interview: Paracrine’s Christopher J. Calhoun Shares Insight on the First Autologous, Device-Based Cell Therapy Platform

Contact US

OUR INFORMATION

FOLLOW US